This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2015 Apr 2;4(4):e001891.

doi: 10.1161/JAHA.115.001891.

Treatment, behavioral, and psychosocial components of cardiovascular disease risk among survivors of childhood and young adult cancer

Amy M Berkman¹, Susan G Lakoski²

Affiliations

Affiliations

¹ Office of Health Promotion Research, University of Vermont, Burlington, VT (A.M.B.).
² Department of Internal Medicine, University of Vermont, Burlington, VT (S.G.L.) Vermont Center on Behavior Health and Vermont Cancer Center, Burlington, VT (S.G.L.).

PMID: 25836057
PMCID: PMC4579959
DOI: 10.1161/JAHA.115.001891

Review

Treatment, behavioral, and psychosocial components of cardiovascular disease risk among survivors of childhood and young adult cancer

Amy M Berkman et al. J Am Heart Assoc. 2015.

. 2015 Apr 2;4(4):e001891.

doi: 10.1161/JAHA.115.001891.

Authors

Amy M Berkman¹, Susan G Lakoski²

Affiliations

¹ Office of Health Promotion Research, University of Vermont, Burlington, VT (A.M.B.).
² Department of Internal Medicine, University of Vermont, Burlington, VT (S.G.L.) Vermont Center on Behavior Health and Vermont Cancer Center, Burlington, VT (S.G.L.).

PMID: 25836057
PMCID: PMC4579959
DOI: 10.1161/JAHA.115.001891

No abstract available

Keywords: heart diseases; population; risk factors.

PubMed Disclaimer

Similar articles

The prevention of cardiovascular disease in cancer survivors.
Daher IN, Daigle TR, Bhatia N, Durand JB. Daher IN, et al. Tex Heart Inst J. 2012;39(2):190-8. Tex Heart Inst J. 2012. PMID: 22740730 Free PMC article.
Survivorship after childhood, adolescent, and young adult cancer.
Tonorezos ES, Oeffinger KC. Tonorezos ES, et al. Cancer J. 2008 Nov-Dec;14(6):388-95. doi: 10.1097/PPO.0b013e31818f5aba. Cancer J. 2008. PMID: 19060603 Review.
Cardiovascular disease in cancer survivors.
Okwuosa TM, Anzevino S, Rao R. Okwuosa TM, et al. Postgrad Med J. 2017 Feb;93(1096):82-90. doi: 10.1136/postgradmedj-2016-134417. Epub 2016 Oct 8. Postgrad Med J. 2017. PMID: 28123076 Review.
Anthracycline cardiotoxicity in childhood.
Ruggiero A, Ridola V, Puma N, Molinari F, Coccia P, De Rosa G, Riccardi R. Ruggiero A, et al. Pediatr Hematol Oncol. 2008 Jun;25(4):261-81. doi: 10.1080/08880010802016649. Pediatr Hematol Oncol. 2008. PMID: 18484471 Review.
Cardiac complications in childhood cancer survivors treated with anthracyclines.
Franco VI, Lipshultz SE. Franco VI, et al. Cardiol Young. 2015 Aug;25 Suppl 2:107-16. doi: 10.1017/S1047951115000906. Cardiol Young. 2015. PMID: 26377717 Review.

See all similar articles

Cited by

Knowledge and attitude on childhood cancer survivorship among healthcare trainees: a multicentre study from India.
Grewal A, Bansal B, Mittal C, Gupta H, Sasi A, Ganesan P, Dabas A, Sahi P, Ramamoorthy L, Lalthanthuami HT, Ramamoorthy J, Sindhu A, Arora S, Bhukya A, Hepzibah M, Devi K, Krishnamurthy K, Rai SK, Mehta N, Antil K, Bakhshi S, Ganguly S. Grewal A, et al. Fam Med Community Health. 2024 Apr 4;12(Suppl 2):e002618. doi: 10.1136/fmch-2023-002618. Fam Med Community Health. 2024. PMID: 38575353 Free PMC article.
Risk of anthracycline-induced cardiac dysfunction in adolescent and young adult (AYA) cancer survivors: role of genetic susceptibility loci.
Stafford LK, Tang X, Brandt A, Ma J, Banchs J, Livingston JA, Roth ME, Morrison AC, Hildebrandt MAT. Stafford LK, et al. Pharmacogenomics J. 2024 Jun 29;24(4):21. doi: 10.1038/s41397-024-00343-0. Pharmacogenomics J. 2024. PMID: 38951505 Free PMC article.
Letter to the Editor: Left Ventricle Size Correlates with Peak Exercise Capacity in Pediatric Cancer Survivors Exposed to Anthracycline Chemotherapy.
Ali H, Majeed K. Ali H, et al. Pediatr Cardiol. 2025 Apr 16. doi: 10.1007/s00246-025-03867-9. Online ahead of print. Pediatr Cardiol. 2025. PMID: 40234260 No abstract available.
Juvenile competitive triathlete after cardiotoxic anthracycline therapy for Acute Myeloid Leukemia.
von Korn P, Vogt M, Oberhoffer R, Ewert P, Müller J. von Korn P, et al. Cardiooncology. 2016 Oct 14;2(1):8. doi: 10.1186/s40959-016-0016-0. Cardiooncology. 2016. PMID: 33530145 Free PMC article.
Does Daily Physical Activity Level Determine the Physical Efficiency of Children After Treatment of Leukemia?
Malicka I, Kowaluk A, Woźniewski M. Malicka I, et al. Int J Environ Res Public Health. 2020 Jan 1;17(1):307. doi: 10.3390/ijerph17010307. Int J Environ Res Public Health. 2020. PMID: 31906384 Free PMC article.

See all "Cited by" articles

References

1. Bleyer A, O'Leary M, Barr R, Ries LAG, eds. Cancer epidemiology in older adolescents and young adults 15 to 29 years of age, including SEER incidence and survival: 1975–2000. 2006; Pub. No. 06x20105767. National Cancer Institute: Bethesda, MD.
1. Ward E, DeSantis C, Robbins A, Kohler B, Jemal A. Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin. 2014; 64:83-103. - PubMed
1. United States Cancer Statistics: 1999–2011 incidence, WONDER online database. 2014.
1. StatBite: trends in U.S. childhood cancer survival (1975–2004). J Natl Cancer Inst. 2009; 101:909. - PubMed
1. National Cancer Institute. Closing the gap: Research and care imperatives for adolescents and young adults with cancer. Bethesda: US Department of Health and Human Services, National Institutes of Health, National Cancer Institute; and the LiveStrong Young Adult Alliance. 2006.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources